Search

Your search keyword '"Matsumoto, Ryuji"' showing total 501 results

Search Constraints

Start Over You searched for: Author "Matsumoto, Ryuji" Remove constraint Author: "Matsumoto, Ryuji"
501 results on '"Matsumoto, Ryuji"'

Search Results

1. Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement

2. PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer

5. Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy

7. Validation and motion analyses of laparoscopic radical nephrectomy with Thiel-embalmed cadavers

10. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study

11. Objective evaluation of laparoscopic surgical skills in wet lab training based on motion analysis and machine learning

12. Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN

13. Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS‐JAPAN).

14. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

15. Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

16. Validation of the Japanese version of the Body Image Scale for bladder cancer patients

17. Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial

18. Supplementary Tables S1-S5 from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma

19. Data from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma

20. Supplementary Legends from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma

21. Supplementary Figure S1 from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma

23. Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN

25. Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index

26. The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

29. A surgical instrument motion measurement system for skill evaluation in practical laparoscopic surgery training.

30. TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma

31. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy

32. Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

33. Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study

35. Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities

36. Impact of postoperative complications on long-term survival in bladder cancer patients

38. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy.

40. MP22-17 THE BODY IMAGE SCALE (BIS) CAN IDENTIFY SYMPTOMS RELATED TO BODY IMAGE AFTER BLADDER CANCER TREATMENT: VALIDATION OF THE JAPANESE VERSION OF THE BIS

41. MP48-20 MENTAL WORKLOADS OF SURGEONS IN UROLOGY: A PROSPECTIVE OBSERVATIONAL STUDY

42. Correction to: Motion analysis for better understanding of psychomotor skills in laparoscopy: objective assessment-based simulation training using animal organs

43. This title is unavailable for guests, please login to see more information.

46. Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort

47. Development and validation of a measurement system for laparoscopic surgical procedures in practical surgery training

48. 診断に苦慮した陰茎発生顆粒球性肉腫の1例

50. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study

Catalog

Books, media, physical & digital resources